Prostate Cancer Risk in the Swedish AMORIS Study The Interplay Among Triglycerides, Total Cholesterol, and Glucose

被引:88
作者
Van Hemelrijck, Mieke [1 ]
Garmo, Hans [1 ,2 ]
Holmberg, Lars [1 ,2 ]
Walldius, Goran [3 ,4 ]
Jungner, Ingmar [5 ,6 ]
Hammar, Niklas [4 ,7 ]
Lambe, Mats [2 ,8 ]
机构
[1] Kings Coll London, Canc Epidemiol Unit, Sch Med, Div Canc Studies, London SE1 9RT, England
[2] Uppsala Univ, Reg Oncol Ctr, Uppsala, Sweden
[3] Karolinska Inst, Inst Environm Med, Dept Med, S-10401 Stockholm, Sweden
[4] Karolinska Inst, Inst Environm Med, Dept Epidemiol, S-10401 Stockholm, Sweden
[5] Karolinska Inst, Clin Epidemiol Unit, Dept Med, S-10401 Stockholm, Sweden
[6] CALAB Res, Stockholm, Sweden
[7] AstraZeneca R&D, Sodertalje, Sweden
[8] Karolinska Inst, Dept Med Epidemiol & Biostat, S-10401 Stockholm, Sweden
基金
英国惠康基金;
关键词
prostate cancer; total cholesterol; triglycerides; glucose; hypercholesterolemia; hypertriglyceridemia; APOLIPOPROTEIN MORTALITY RISK; METABOLIC SYNDROME; DIABETES-MELLITUS; A-I; LIPOPROTEIN COMPONENTS; MYOCARDIAL-INFARCTION; SERUM-CHOLESTEROL; MEN; HYPERCHOLESTEROLEMIA; REGISTER;
D O I
10.1002/cncr.25758
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
BACKGROUND: In a cohort including 5112 prostate cancer (pCa) patients, the authors investigated associations among triglycerides (TG), total cholesterol (TC), and pCa while taking into account glucose. METHODS: A cohort (n = 200,660) based on 4 groups of men, according to age at cohort entry, with TG, TC, and glucose measurements was selected from the Apolipoprotein MOrtality RISk (AMORIS) database. Of these, 5112 men developed pCa. Multivariate Cox proportional hazard models were used to analyze associations among TG, TC, and pCa. Competing risks were assessed graphically. RESULTS: Age-stratified analyses for quartiles of TG, TC, and glucose showed a negative association between glucose and pCa risk (HR, 0.93; 95% CI, 0.86-1.01), 0.93 (0.86-1.01), 0.87 (0.81-0.94) for the second, third, and fourth quartiles compared with the first (P-trend = .001). Stratified analysis by glucose levels (< 6.11 or >= 6.11 mmol/L) showed a positive association between hypertriglyceridemia (TG >= 1.71 mmol/L) and pCa risk, when there were high glucose levels (HR, 1.23; 95% CI, 1.01-1.48). No association was found for hypercholesterolemia (TC >= 6.50 mmol/L). Competing risk analysis showed that protective effects of glucose were overestimated in conventional Cox proportional hazard models and strengthened positive findings between TG and pCa risk. CONCLUSIONS: The authors' findings supported the hypothesis that factors of the glucose and lipid metabolism influence pCa risk. Competing risk assessment showed that it is important to take into account the long natural history and age distribution of pCa when interpreting results. The authors' findings indicate another reason to fight the increasing prevalence of obesity and dyslipidemia. Cancer 2011; 117: 2086-95. (C) 2010 American Cancer Society.
引用
收藏
页码:2086 / 2095
页数:10
相关论文
共 38 条
[1]
Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of Cancer [J].
Ahn, Jiyoung ;
Lim, Unhee ;
Weinstein, Stephanie J. ;
Schatzkin, Arthur ;
Hayes, Richard B. ;
Virtamo, Jarmo ;
Albanes, Demetrius .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (11) :2814-2821
[2]
The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[3]
[Anonymous], 2007, STAT AREAS HLTH MED
[4]
Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer [J].
Bravi, F ;
Scotti, L ;
Bosetti, C ;
Talamini, R ;
Negri, E ;
Montella, M ;
Franceschi, S ;
La Vecchia, C .
ANNALS OF ONCOLOGY, 2006, 17 (06) :1014-1017
[5]
History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study [J].
Calton, Brook A. ;
Chang, Shih Chen ;
Wright, Margaret E. ;
Kipnis, Victor ;
Lawson, Karla ;
Thompson, Frances E. ;
Subar, Amy F. ;
Mouw, Traci ;
Campbell, David S. ;
Hurwitz, Paul ;
Hollenbeck, Albert ;
Schatzkin, Arthur ;
Leitzmann, Michael F. .
CANCER CAUSES & CONTROL, 2007, 18 (05) :493-503
[6]
*CENTR BUR STAT, 2008, STAT SWED
[7]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]
Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database [J].
Freedland, S. J. ;
Banez, L. L. ;
Sun, L. L. ;
Fitzsimons, N. J. ;
Moul, J. W. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2009, 12 (03) :259-263
[9]
Giovannucci E, 1999, CANCER EPIDEM BIOMAR, V8, P277
[10]
Obesity, diabetes, and risk of prostate cancer: Results from the prostate cancer prevention trial [J].
Gong, Zhihong ;
Neuhouser, Marian L. ;
Goodman, Phyllis J. ;
Albanes, Demetrius ;
Chi, Chen ;
Hsing, Ann W. ;
Lippman, Scott M. ;
Platz, Elizabeth A. ;
Pollak, Michael N. ;
Thompson, Ian M. ;
Kristal, Alan R. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (10) :1977-1983